Outcomes of retinopathy of prematurity screening at National Center For Maternal And Child Health
- VernacularTitle:ЭХЭМҮТ –д дутуу нярайн нүдний торлогийн эмгэг илрүүлэх скрининг үзлэгийн үр дүн
- Author:
Tsengelmaa Ch
1
;
Erdenetuya G
2
;
Tsogzolmaa G
3
;
Gantuya M
2
;
Amgalan P
3
;
Enkhtuya S
4
;
Altantuya Ts
4
;
Bayalag M
4
Author Information
1. Department of Pediatric Ophthalmology, National Center for Maternal and Child Health, Ulaanbaatar, Mongolia
2. Central Hospital of Orkhon province, Mongolia
3. Central Hospital of Zavkhan province, Mongolia
4. Childrens Hospital, National Center for Maternal and Child Health, Ulaanbaatar, Mongolia
- Publication Type:Journal Article
- Keywords:
ROP;
Laser;
NCMCH
- From:Innovation
2021;14(1-Ophthalmology):22-25
- CountryMongolia
- Language:Mongolian
-
Abstract:
Purpose:To investigate the outcomes of ROP screening of retinopathy of prematurity (ROP).
Methods:This was a prospective of prematurity infants screened ROP from 2020 April 13th to
April 28th 2020 and from 2020 June 08 th to June 22th 2020 and prospective cohort study of
premature infants with treatment-requiring ROP who received intravitreal injections, laser surgery.
Demographic factors, diagnosis and clinical course were recorded. Indirect ophthalmoscopy
and Retinal imaging was performed using RetCam (Natus Medical, Pleasanton, CA) and
images were taken. Each eye was evaluated by the pediatric ophthalmologist and aimag’s
ophthalmologist for the presence or absence of ROP, zone of vascularization, stage, plus disease,
and aggressive posterior ROP (AP-ROP). The diagnosis and classification of ROP for this current
study were determined by examination using indirect ophthalmoscopy, and treatment plans
were determined according to the International Classification for ROP and the Early Treatment for
ROP Study (ET-ROP).2,13
Results:A total of 90 premature infants with BW ≤ 2000g and/or GA ≤ 34 weeks were screened for
ROP during the study period. 8 (8.8%) of the 90 infants screened required treatment. The 8 infants
who received ROP treatment had a mean GA of 28.5 ± 1.7 weeks, mean BW of 1237.5 ± 125.42g,
mean PMA of 36 weeks and mean follow-up time of 2 months.
Conclusion:After treatment, resolution of ROP was noted in approximately 100 % of the patients
who had treatment-requiring ROP.
- Full text:InnoOpht-2021-14(1);22-25.pdf
